Trial NCT04452318
Publication O Brien M P, medRxiv, 2021
Primary outcome on the report: The proportion of participants who subsequently developed symptomatic Covid-19 during a 28-day efficacy assessment period.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.